✦ LIBER ✦

Treatment of subacute sclerosing panencephalitis with alpha interferon

✍ Scribed by Generoso G. Gascon; Soad Yamani; A. Cafege; L. Flock; S. Al-Sedairy; R. S. Parhar; J. Crowell; Michael Nester; Imad Kanaan; Mohammed A. Jallu

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 251 KB
Volume: 30
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410300227

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraventricular interferon treatment fo

Intraventricular interferon treatment for subacute sclerosing panencephalitis

✍ I. Wirguin; I. Steiner; T. Brenner; O. Abramsky 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Apparent response of subacute sclerosing

Apparent response of subacute sclerosing panencephalitis to intrathecal interferon alpha

✍ Dr Masahito Miyazaki; Toshiaki Hashimoto; Kayo Fujino; Tomoko Goda; Masanobu Tay 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

Intrathecal interferon in subacute scler

Intrathecal interferon in subacute sclerosing panencephalitis

✍ Dr Peter R. Huttenlocher; Daniel L. Picchietti; Raymond P. Roos; Neil R. Cashman 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Resolving MRI abnormalities with progres

Resolving MRI abnormalities with progression of subacute sclerosing panencephalitis

✍ J. B. Winer; M. Pires; A. Kermode; L. Ginsberg; M. Rossor 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 693 KB

Isoprinosine treatment in 18 patients wi

Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled study

✍ Fuad Sami Haddad; Dr Winthrop S. Risk 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB

Transfer factor therapy in patients with

Transfer factor therapy in patients with subacute sclerosing panencephalitis

✍ Y. M. Käckell; P. J. Grob; W. H. Kreth; R. Kibler; V. ter Meulen 📂 Article 📅 1975 🏛 Springer 🌐 English ⚖ 674 KB

Thirteen patients with subacute sclerosing panencephalitis (S.S.P.E.) at different stages of the disease were admitted for transfer factor treatment. The transfer factor was prepared from non-selected blood bank donors. The activity of the transfer factor was tested in patients with diseases other t